Treatment of human skin carcinoma cells (A431) with EGCG had resulted in a reduction of DNA methylation, which in turn led to protein expression of the DNA hypermethylation-silenced tumor suppressor genes, p16INK4a and CDK interacting protein 1/p21 (Cip1/p21). The gene discussed is CDKN1A; the disease is skin carcinoma.